All News about Viridian Therapeutics Inc
![](https://www.investors.com/wp-content/uploads/2018/10/Stock-DrugSpill-02-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/739274/biotech-gettyimages-1215565992.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/11/better_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/11/vrdn.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
11 Analysts Have This to Say About Viridian Therapeutics
June 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_8038.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Viridian Therapeutics
May 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Viridian Therapeutics Q1 Earnings
May 09, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/11/jetblue_airways_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230710883161/en/1837488/22/Viridian_Logo1.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Viridian Therapeutics
May 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Viridian Therapeutics
April 17, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Viridian Therapeutics's Future
March 30, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230706577364/en/1835469/22/Viridian_Logo1.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Viridian Therapeutics's Future
March 09, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230613522439/en/1817182/5/Viridian_Logo1.jpg)
![](https://mms.businesswire.com/media/20230605005776/en/1811148/5/Viridian_Logo1.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Viridian Therapeutics Earnings Preview
March 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Viridian Therapeutics
February 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/09/vrdn_mark_dark__4ae211cd0083583e94d0ba0b1e0e4450.png?width=1200&height=800&fit=crop)
Via Benzinga
Viridian Therapeutics Earnings Perspective: Return On Capital Employed
December 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1563.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
December 19, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.